Clinical Trial Update: Greater Occipital Nerve (GON) Block Effectivity in the Treatment of Chronic Migraine: 6 Months Follow up [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating greater occipital nerve block for chronic migraine was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine Disorders

Snippet

Sponsor: Bozok University | Conditions: Migraine Disorders | Phase 4 | Status: WITHDRAWN